Volume 18, Issue 3 (Autumn 2026)
nkums 2026, 18(3): 26-35 |
Back to browse issues page
Ethics code: IR.TBZMED.REC.1404.134
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aghebati-Maleki L, Ebrahimi V, Sandoghchian Shotorbani S, Aghazadeh Balkanlou G, Soltani-Zangbar M S. Induction of Mitochondrial Apoptosis and Suppression of Autophagic Pathways in T-Cell Acute Lymphoblastic Leukemia Cells by Natural Killer Cell–Derived Exosomes. nkums 2026; 18 (3) :26-35
URL: http://journal.nkums.ac.ir/article-1-3424-en.html
URL: http://journal.nkums.ac.ir/article-1-3424-en.html
Leili Aghebati-Maleki1 
, Vida Ebrahimi2 , Siamak Sandoghchian Shotorbani1 , Ghasem Aghazadeh Balkanlou3 , Mohammad Sadegh Soltani-Zangbar *4
, Vida Ebrahimi2 , Siamak Sandoghchian Shotorbani1 , Ghasem Aghazadeh Balkanlou3 , Mohammad Sadegh Soltani-Zangbar *4
1- Associate Professor, Ph.D. in Medical Immunology, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2- Ph.D. in Pharmaceutical Biotechnology, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3- MD, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Assistant Professor, Ph.D. in Medical Immunology, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ,soltanim@tbzmed.ac.ir
2- Ph.D. in Pharmaceutical Biotechnology, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3- MD, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Assistant Professor, Ph.D. in Medical Immunology, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ,
Abstract: (47 Views)
Introduction: Acute lymphoblastic leukemia (ALL) is one of the most common hematologic malignancies, in which treatment resistance and disease relapse remain major clinical challenges. Natural killer (NK) cells release exosomes containing cytotoxic molecules that can exert anti-tumor effects without requiring direct cell-to-cell contact. Considering the critical role of the apoptosis–autophagy balance in leukemic cell survival, the present study aimed to investigate the effect of NK cell–derived exosomes on this regulatory axis in the MOLT-4 cell line.
Methods: In this experimental study, NK cells were isolated from the peripheral blood of healthy donors using magnetic-activated cell sorting (MACS) and activated with IL-2. Exosomes were extracted from culture supernatants and characterized in terms of morphology and size. MOLT-4 cells were then treated with NK-derived exosomes for 48 h. Apoptosis was assessed by flow cytometry using Annexin V/PI staining. The expression levels of BAX, BCL2, Caspase-9 (CASP9), Beclin-1 (BECN1), ATG5, LC3B, and FOXO1 were evaluated by quantitative real-time PCR.
Results: Treatment with NK cell–derived exosomes significantly increased the percentage of apoptotic cells (P < 0.001). Expression levels of BAX (P < 0.0005) and CASP9 (P < 0.0014) were significantly upregulated, while BCL2 expression (P < 0.05) was downregulated, resulting in an increased BAX/BCL2 ratio. Concurrently, the expression of autophagy-related genes, including BECN1 (P < 0.013), ATG5 (P < 0.009), and LC3B (P < 0.037), as well as the transcription factor FOXO1 (P < 0.01), was significantly decreased.
Conclusion: NK cell–derived exosomes reduce the survival of acute lymphoblastic leukemia cells by inducing intrinsic apoptotic pathways and suppressing autophagic signaling. These findings suggest that NK-derived exosomes may represent a novel strategy in extracellular vesicle–based immunotherapy.
Methods: In this experimental study, NK cells were isolated from the peripheral blood of healthy donors using magnetic-activated cell sorting (MACS) and activated with IL-2. Exosomes were extracted from culture supernatants and characterized in terms of morphology and size. MOLT-4 cells were then treated with NK-derived exosomes for 48 h. Apoptosis was assessed by flow cytometry using Annexin V/PI staining. The expression levels of BAX, BCL2, Caspase-9 (CASP9), Beclin-1 (BECN1), ATG5, LC3B, and FOXO1 were evaluated by quantitative real-time PCR.
Results: Treatment with NK cell–derived exosomes significantly increased the percentage of apoptotic cells (P < 0.001). Expression levels of BAX (P < 0.0005) and CASP9 (P < 0.0014) were significantly upregulated, while BCL2 expression (P < 0.05) was downregulated, resulting in an increased BAX/BCL2 ratio. Concurrently, the expression of autophagy-related genes, including BECN1 (P < 0.013), ATG5 (P < 0.009), and LC3B (P < 0.037), as well as the transcription factor FOXO1 (P < 0.01), was significantly decreased.
Conclusion: NK cell–derived exosomes reduce the survival of acute lymphoblastic leukemia cells by inducing intrinsic apoptotic pathways and suppressing autophagic signaling. These findings suggest that NK-derived exosomes may represent a novel strategy in extracellular vesicle–based immunotherapy.
Type of Study: Orginal Research |
Subject:
Basic Sciences
Received: 2026/04/12 | Accepted: 2026/06/20 | Published: 2026/09/29
Received: 2026/04/12 | Accepted: 2026/06/20 | Published: 2026/09/29
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
